Pancreatic Cancer New Indication: Sotorasib in kRAS G12C Mutant Pancreatic Cancer Ulas D. Bayraktar, MD 2023-03-15
Non-Small Cell Lung Cancer New Indication: Adjuvant Pembrolizumab for NSCLC Ulas D. Bayraktar, MD 2023-03-15
Colorectal Cancer New Protocol: Tucatinib and Trastuzumab for Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Bladder Cancer New Reference: Neoadjuvant CISplatin and Gemcitabine for Urothelial Cancer Ulas D. Bayraktar, MD 2023-03-15
Breast Cancer New Indication: Sacituzumab Govitecan for HR+, her2 Negative Breast Cancer Ulas D. Bayraktar, MD 2023-03-15
Colorectal Cancer New Indication: Encorafenib, Binimetinib, and Cetuximab for bRAF V600E Mutant Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Waldenstrom macroglobulinemia New Reference: Bortezomib, Rituximab, Cyclophosphamide for Waldenstrom Ulas D. Bayraktar, MD 2023-03-15
